Clinical Trial Update: New Treatment for Donor Sites [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating a new treatment for burn donor-site wounds has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn Injuries

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Burn | Phase 2, Phase 3 | Status: WITHDRAWN